Key result
Transitional care interventions cut rehospitalization by ~41% versus usual care in stroke survivors.
Why the study?
The study was conducted to evaluate the effects of transitional care interventions on rehospitalization, functional outcomes, quality of life, mortality, and disability in stroke survivors.
Do transitional care interventions reduce rehospitalization and improve functional outcomes in adult stroke survivors?
Meta-Analysis (n=3,520)
Do transitional care interventions reduce rehospitalization and improve functional outcomes in adult stroke survivors?
Relative Risk: 0.59 (95% CI 0.4–0.88)
p-value: p=0.010
Transitional care interventions significantly reduce short-term rehospitalization and improve quality of life in stroke survivors, though they do not show a clear mortality benefit.
Supports broader adoption of transitional care post-discharge; confirms efficacy across pooled randomized evidence.
Objective To evaluate the effects of transitional care interventions on rehospitalization, functional outcomes, quality of life, mortality, and disability in stroke survivors. Methods This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement and registered in PROSPERO (CRD420251266063). PubMed, Web of Science, Embase, the Cochrane Library, and CINAHL were searched from inception to May 13, 2026. Additional searches were conducted in ClinicalTrials.gov , Google Scholar, and grey literature sources. Randomized controlled trials comparing transitional care interventions with usual care in adult stroke survivors were included. Dichotomous outcomes were pooled as risk ratios (RRs), and continuous outcomes were pooled as standardized mean differences (SMDs), both with 95% confidence intervals (CIs). Subgroup analyses were conducted according to follow-up duration. Sensitivity analyses, small-study-effect assessment, and GRADE certainty assessment were performed where appropriate. Results Twenty-four randomized controlled trials involving 3,520 stroke survivors were included. Transitional care interventions reduced overall rehospitalization compared with usual care (RR = 0.59, 95% CI 0.40–0.88), with a more consistent effect within 3 months after discharge (RR = 0.49, 95% CI 0.29–0.82). Transitional care interventions improved activities of daily living (ADL) in the primary analysis (SMD = 0.43, 95% CI 0.20–0.67), although heterogeneity was substantial; after sensitivity analysis, the effect remained statistically significant but was attenuated (SMD = 0.22, 95% CI 0.07–0.37). Quality of life (QoL) improved overall (SMD = 0.67, 95% CI 0.37–0.96), particularly within 3 months (SMD = 0.74, 95% CI 0.54–0.94). No significant mortality reduction was observed (RR = 0.86, 95% CI 0.53–1.39). Transitional care interventions were associated with lower short-term disability measured by the modified Rankin Scale (mRS; SMD = −0.59, 95% CI −0.99 to −0.19), but this finding was limited by substantial heterogeneity. The certainty of evidence was moderate for short-term rehospitalization and short-term QoL, and low for ADL, mortality, and disability. Conclusion Transitional care interventions probably reduce short-term rehospitalization and improve short-term QoL in stroke survivors. They may also improve ADL and short-term disability, but these findings should be interpreted cautiously because of heterogeneity, risk of bias, and possible small-study effects. Current evidence does not establish a clear mortality benefit.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) conducted a meta-analysis in Stroke (n=3,520). Transitional care interventions vs. Usual care was evaluated on Overall rehospitalization (RR 0.59, 95% CI 0.40-0.88, p=0.010). Transitional care interventions significantly reduced overall rehospitalization compared with usual care in stroke survivors (RR 0.59).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: